Aspen Neuroscience ASPE

ARCH Venture Partners XIV, L.P. (10% owner) bought 1,200,000 ASPE at $15.00, worth $18M

Form
4
Filed
Importance
Major
  1. Arch Venture Partners XIV, L.P. acquired 1,200,000 common shares
  2. Transaction date: Nov 2, 2026
  3. Ownership form: Direct

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Get an email when Aspen Neuroscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

  1. The filing provides details about the ownership structure and the type of securities held.
  2. It also includes the address of the reporting person and the ticker symbol for the issuer, [ASPE].

2 of 3 claims matched the filing text.

Not found in the filing text

  • BERNS PAUL L filed a Form 4 on November 2, 2026, reporting changes in beneficial ownership of securities.

From the filing

Filing text

SEC Form 4

FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287

Estimated average burden hours per response: 0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.

See

Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person * ARCH Venture Partners XIV, L.P.

(Last) (First) (Middle)

8755 W. HIGGINS ROAD, SUITE 10252

(Street) CHICAGO

ILLINOIS

60631

(City) (State) (Zip)

UNITED STATES

(Country) 2. Issuer Name and Ticker or Trading Symbol

Aspen Neuroscience, Inc.2

[ ASPE ]2

5. Relationship of Reporting Person(s) to Issuer

(Check all applicable) Director X 10% Owner

Officer (give title below) Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction

(Month/Day/Year)

11/02/2026 6. Individual or Joint/Group Filing (Check Applicable Line)

Form filed by One Reporting Person

X Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed

(Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned1

1. Title of Security (Instr.

3)

2. Transaction Date

(Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr.

8)

4. Securities Acquired (A) or Disposed Of (D) (Instr.

3, 4 and 5)

5.

Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.

3 and 4)

6. Ownership Form: Direct (D) or Indirect (I) (Instr.

4)

7. Nature of Indirect Beneficial Ownership (Instr.

4)

Code V Amount (A) or (D) Price

Common Stock 11/02/202

Similar companies

Same SIC code (2834) and public float not reported.